1st Quarter - Report

HOWARD CONSULTING GROUP, INC. for PARATEK PHARMACEUTICALS

Period 1st Quarter 2019 Filed Apr 23, 2019 Signed by Frank Howard, Jr.

Official filing
Firm
HOWARD CONSULTING GROUP, INC.
Client
PARATEK PHARMACEUTICALS
Income
$12,250
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

- Funding of antimicrobial research, development and investments - Strategic National Stockpile(s) (CDC, DoD, DHS) - Drug rebates

LobbyistCovered position, as disclosed
FRANK HOWARD —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS)

Defense DEF

- Funding of antimicrobial research, development and investments - Strategic National Stockpile(s) (CDC, DoD, DHS) - Drug rebates

LobbyistCovered position, as disclosed
FRANK HOWARD —

Contacted: Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.